Yüklüyor......
Prediction of Metabolic Interactions With Oxycodone via CYP2D6 and CYP3A Inhibition Using a Physiologically Based Pharmacokinetic Model
Evaluation of a potential risk of metabolic drug–drug interactions (DDI) is of high importance in the clinical setting. In this study, a physiologically based pharmacokinetic (PBPK) model was developed for oxycodone and its two primary metabolites, oxymorphone and noroxycodone, in order to assess di...
Kaydedildi:
| Yayımlandı: | CPT Pharmacometrics Syst Pharmacol |
|---|---|
| Asıl Yazarlar: | , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Nature Publishing Group
2014
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4288002/ https://ncbi.nlm.nih.gov/pubmed/25518025 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/psp.2014.49 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|